1)Brown GC, Magargal LE:Central retinal artery obstruction and visual acuity. Ophthalmology 89:14-19, 1982
2)Ros MA, Magargal LE, Uram M:Branch retinal-artery obstruction:a review of 201 eyes. Ann Ophthalmol 21:103-107, 1989
3)Kollarits CR, Lubow M, Hissong LS:Retinal strokes. Ⅰ. Incidence of carotid atheromata. JAMA222:1273-1280, 1972
4)Vine AK, Samama MM:The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 37:283-292, 1993
5)Mangat HS:Retinal artery occlusion. Surv Ophthalmol 40:145-155, 1995
6)Bressler NM, Bressler SB:The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 37:283-292, 1993
7)Gass JDM, Tiedeman J, Thomas M:Idiopathic recurrent branch retinal arterial occlusion. Ophthalmology 93:1148-1157, 1986
8)Hayreh SS, Podhajsky P:Ocular neovascularization with retinal vascular occlusion. Ⅱ. Occurrence in central and branch retinal artery occlusion. Arch Ophthalmol 100:1585-1596, 1982
点滴静注療法.現代医療編集委員会(編):プロスタグランディンの新しい展開.420-432,現代医療社,東京,1984
is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man. J Pharm Pharmacol 35:666-667, 1983
incorporated in lipid microspheres on thrombus formation and thrombus disaggregation and its potential to target to the site of vascular lesions. Arznei Forsch 36:1206-1209, 1986
12)笹野久美子,安藤文隆:治療薬としてのプロスタグランディン―眼科領域.現代医学 39:17-23,1991
. Plast Reconstr Surg 111:2307-2314, 2003
14)居出上大祐・松尾信彦・江口晃二・他:治療に奏効した網膜中心動脈閉塞症の1症例.あたらしい眼科 5:107-110,1988
15)Imasawa M, Morimoto T, Iijima H:Recovery of visual field loss due to central retinal artery occlusion. Jpn J Ophthalmol 48:294-299, 2004
. Angiology 54:491-493, 2003
. Prostaglandins Leukot Med 13:281-288, 1984
18)Liversedge LA, Smith VH:Neuromedical and ophthalmic aspects of central retinal artery occlusion. Trans Ophthalmol Soc UK 82:571-576, 1962
19)中尾雄三・駒井義彦・宇高ひとみ・他:眼底血管閉塞症と脳卒中の関連性について.眼紀 33:544-548,1982